Home
Certara's Better Drug Development Process
The drug development process is long and expensive with more failures than successes.
At Certara, we support confident decision-making throughout the entire drug development process with our gold-standard software and technology-enabled services, helping our partners to reduce cycle times, lower costs, and improve outcomes for patients. In fact, eleven regulatory agencies worldwide have adopted our Phoenix™ PK/PD and/or Simcyp™ PBPK Simulator software platforms, including the US FDA and EMA.
Our results speak for themselves. 90% of new drug approvals by the FDA have been supported by our software or services since 2014.
How we help our clients
Integrated Drug Development
We tailor clinical pharmacology, pharmacometrics, pharmacokinetic and pharmacodynamic (PK/PD) analysis, and regulatory strategies to get to proof of concept faster, choose the right dose, and reduce clinical trial size or avoid certain trials altogether.
Regulatory Science
We accelerate regulatory submissions and approvals with customized regulatory submission strategy, communications and operations, powered by our proprietary artificial intelligence technology and supported by the GlobalSubmit™ eCTD platform.
Biosimulation and Informatics Software
We provide software spanning the entire drug development lifecycle, from D360™ scientific informatics to mechanistic modeling with the Simcyp™ PBPK Simulator and Quantitative Systems Pharmacology and the Phoenix™ PK/PD platform.
Evidence, Value and Access
We optimize value with decision analytics and modeling, value and access consulting, and real world data solutions, powered by our HOPE™ Bayesian modeling engine and communicated via our BaseCase™ platform.
Latest from Certara
Join our team
Our people are our success. Teamwork and our individual differences, experiences, and capabilities are essential not only to delivering on our customer commitments but also to fostering our collaborative culture and world-class reputation.
We help to empower our partners to make informed decisions by using our expertise and experience in quantitative clinical pharmacology and pharmacometrics.
– Yuan Xiong, PhD Director, Integrated Drug Development
Success isn’t just measured financially at Certara. It is measured in terms of the submissions we have authored, the speed with which we publish documents to regulators, and the technology we deploy to accelerate access to new health technologies. It’s such a pleasure to be part of this ensemble of amazing talent at Certara. I learn new things every day from talented colleagues and clients alike.
– Justin Edge President, Regulatory Science and Evidence & Access
Here at Certara I have access to key experts, and there is great sharing of knowledge and collective team spirit. We are surrounded by great leaders who are still doing science and inspiring work. Every day we make a difference by pushing the boundaries of science forward for our clients and eventually the patients.
– Eva Gil Berglund, PhD Senior Director, Regulatory Strategy